UroGen Pharma (URGN) Gross Margin (QoQ) (2018 - 2026)

UroGen Pharma (URGN) Gross Margin (QoQ) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 UroGen Pharma 2.05 Bn 1.91 Bn 46.82 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 57.00
Dec 31, 2025 324.00
Sep 30, 2025 273.00
Jun 30, 2025 -316.00
Mar 31, 2025 -144.00
Dec 31, 2024 -33.00
Sep 30, 2024 47.00
Jun 30, 2024 -100.00
Mar 31, 2024 51.00
Dec 31, 2023 164.00
Sep 30, 2023 21.00
Jun 30, 2023 162.00
Mar 31, 2023 -67.00
Dec 31, 2022 4.00
Sep 30, 2022 -143.00
Jun 30, 2022 13.00
Mar 31, 2022 -142.00
Dec 31, 2021 113.00
Sep 30, 2021 -1.00
Jun 30, 2021 103.00